Affiliation:
1. Neuberg Anand Reference Laboratory, Bangalore, Karnataka, India
2. Kauvery Hospital, Tennur, Tamil Nadu, India
Abstract
Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood and represents about 75 -80% of ALL in pediatric age group. ALL is characterised by uncontrolled proliferation of abnormal, immature lymphocytes and their progenitors and replacing the bone marrow elements and other lymphoid organs by leukemic cells (ALL blasts). The 5 year survival rate for childhood ALL is about 90% overall, children in lower risk groups have a better prognosis than those in higher risk group. Risk assessment is mainly based on cytogenetic and molecular factors in addition, clinical symptoms and signs, White blood cell count at diagnosis are all recognized for stratification. In present case the cytogenetic analysis showed the presence of trisomy 5 as a sole numerical abnormality. Trisomy 5 accounts for aneuploidy change in the cytogenetic analysis. The gain or loss of whole chromosome, ie aneuploidy is a major genomic insult in human cancers. Aneuploidy is observed in ~90% of solid tumors and~60% of hematological maignancies. The increased gene expression in trisomy 5 causes chromosomal instability (CIN), microsatellite instability (MIN) and genomic instabilty which inturn causes the cancer genome to undergo evolution, adaptation and favors tumor progression in patients with B cell acute lymphoblastic leukemia.
Publisher
IP Innovative Publication Pvt Ltd
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference10 articles.
1. DG Nathan, SH Orkin, D Ginsburg, AT Look, Nathan and Oski’s Hematology of Infancy and childhood. 6th edn..Epidemiology of leukemia in childhood.1081
2. Puckett Y, Chan O, .Acute Lymphocytic Leukemia.
3. American Cancer Society. Cancer Facts & Figures..
4. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Uniform approach to risk classification and treatmentassignment for children with acute lymphoblastic leukemia.J Clin Oncol 1996;14(1):18-24
5. Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, Clinical significance of minimal residualdisease in childhood acute lymphoblastic leukemia and itsrelationship to other prognostic factors: a Children’sOncology Group Study.Blood 2008;111(12):5477-85